Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 ur...
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
About this item
Full title
Author / Creator
Sternberg, Cora N, Dr , Skoneczna, Iwona, MD , Kerst, J Martijn, PhD , Albers, Peter, Prof , Fossa, Sophie D, Prof , Agerbaek, Mads, MD , Dumez, Herlinde, Prof , de Santis, Maria, MD , Théodore, Christine, MD , Leahy, Michael G , Chester, John D, Prof , Verbaeys, Antony, Prof , Daugaard, Gedske, Prof , Wood, Lori, MD , Witjes, J Alfred, PhD , de Wit, Ronald, Prof , Geoffrois, Lionel, MD , Sengelov, Lisa, DMSc , Thalmann, George, Prof , Charpentier, Danielle, MD , Rolland, Frédéric, MD , Mignot, Laurent, MD , Sundar, Santhanam, MRCP , Symonds, Paul, Prof , Graham, John, FRCP , Joly, Florence, Prof , Marreaud, Sandrine, MD , Collette, Laurence, PhD , Sylvester, Richard, ScD , German Association of Urologic Oncology (AUO) , for the European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group , National Cancer Institute of Canada Clinical Trials Group , National Cancer Research Institute Bladder Cancer Study Group , Groupe d'Etude des Tumeurs Urogénitales , European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group and German Association of Urologic Oncology
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to compare immediate versus deferred cisplatin-based combination chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder. Methods This intergroup, o...
Alternative Titles
Full title
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Authors, Artists and Contributors
Author / Creator
Skoneczna, Iwona, MD
Kerst, J Martijn, PhD
Albers, Peter, Prof
Fossa, Sophie D, Prof
Agerbaek, Mads, MD
Dumez, Herlinde, Prof
de Santis, Maria, MD
Théodore, Christine, MD
Leahy, Michael G
Chester, John D, Prof
Verbaeys, Antony, Prof
Daugaard, Gedske, Prof
Wood, Lori, MD
Witjes, J Alfred, PhD
de Wit, Ronald, Prof
Geoffrois, Lionel, MD
Sengelov, Lisa, DMSc
Thalmann, George, Prof
Charpentier, Danielle, MD
Rolland, Frédéric, MD
Mignot, Laurent, MD
Sundar, Santhanam, MRCP
Symonds, Paul, Prof
Graham, John, FRCP
Joly, Florence, Prof
Marreaud, Sandrine, MD
Collette, Laurence, PhD
Sylvester, Richard, ScD
German Association of Urologic Oncology (AUO)
for the European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group
National Cancer Institute of Canada Clinical Trials Group
National Cancer Research Institute Bladder Cancer Study Group
Groupe d'Etude des Tumeurs Urogénitales
European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group
German Association of Urologic Oncology
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751215523
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215523
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(14)71160-X